ELIFE 润色咨询

eLife

出版年份:暂无数据 年文章数:12320 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:4.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=330712239, cover=https://img.medsci.cn/images/journal/cover/2021/Cvu_202109271314553350.jpg, fullname=eLife, abbr=ELIFE, pyear=暂无数据, frequence=Irregular, articleNumbers=12320, citedSelf2015=4.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.68月, reviewFee=null, pageFee=3000.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2050-084X, greenSci=https://www.greensci.net/search?kw=2050-084X, scijournal=https://www.scijournal.org/impact-factor-of-ELIFE.shtml, medsciHotlightString=null, medsciHotlightRealtime=22.654, medsciHotlight=27.472, medsciHotlight5year=33.9293, citescore=10.6, hIndex=139, impactFactor=7.7, orgnization=eLife Sciences Publications, orgnizationUrl=, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=生物 1区[Top], smallclassCas=生物 2 区, website=http://elifesciences.org/, websiteHits=16119, guideForAuthor=, guideForAuthorHits=34, submitWebsite=https://submit.elifesciences.org/, submitWebsiteHits=7489, content=<span style="font-weight: bold;">Aims & scope</span><br>eLife publishes outstanding research in the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Our 32 Senior editors and 282-member Board of Reviewing Editors are among the most respected and accomplished individuals in their fields – from human genetics and neuroscience to biophysics and epidemiology. Where necessary, our Senior editors will also consult with external guest editors to evaluate new submissions.<div><br></div><div><span style="font-weight: bold;">接收领域</span><br><div><br></div><div><div>BIOCHEMISTRY</div><div>BIOPHYSICS AND STRUCTURAL BIOLOGY</div><div>CANCER BIOLOGY</div><div>CELL BIOLOGY</div><div>COMPUTATIONAL AND SYSTEMS BIOLOGY</div><div>DEVELOPMENTAL BIOLOGY AND STEM CELLS</div><div>ECOLOGY</div><div>EPIDEMIOLOGY AND GLOBAL HEALTH</div><div>GENES AND CHROMOSOMES</div><div>GENOMICS AND EVOLUTIONARY BIOLOGY</div><div>HUMAN BIOLOGY AND MEDICINE</div><div>IMMUNOLOGY</div><div>MICROBIOLOGY AND INFECTIOUS DISEASE</div><div>NEUROSCIENCE</div><div>PLANT BIOLOGY</div><br><span style="font-weight: bold;">2015年数据:</span><br><br>DAYS TO INITIAL DECISION ----4 days<br><br>DAYS TO POST-REVIEW DECISION ---33 days<br><br>DAYS SUBMISSION TO ACCEPTANCE----116 days<br><br>At eLife, we’ve taken a fresh approach to peer review to save you time, and to provide clear direction and constructive input. Decisions are quick and efficient; revision requests are designed to be clear and manageable; and multiple rounds of revision are usually avoided. Here’s how it works:<div><br><span style="font-weight: bold;">Initial decisions are delivered quickly</span></div><div><br>Our Senior editors decide whether initial submissions are appropriate for in-depth peer review, usually in consultation with members of the Board of Reviewing Editors.<br><br><span style="font-weight: bold;">Active scientists make all decisions</span></div><div><br>A Senior editor assigns a member of the Board of Reviewing Editors to oversee the peer-review process. The Reviewing editor usually reviews the article him or herself, calling on one or two additional reviewers as needed.<br><br><span style="font-weight: bold;">Revision requests are consolidated</span></div><div><br>Reviewers get together online to discuss their recommendations, refining their feedback, and striving to provide clear and concise guidance. If the work needs essential revisions before it can be published, the Reviewing editor incorporates those requirements into a single set of instructions.<br><br><span style="font-weight: bold;">Limited rounds of revision</span></div><div><br>Additional rounds of revision are largely eliminated, as the Reviewing editor is able to assess most revised submissions without further outside review.<br><span style="font-weight: bold;"><br>Decisions and responses are available for all to read</span></div><div><br>In the interests of openness and transparency we publish the most substantive parts of the decision letter after review and the associated author responses.<br><br><br><br></div></div></div>, totalCites=94866, brief=ELIFE杂志生物行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=生化与分子生物学" >生化与分子生物学</a></strong>”子行业的顶级杂志, articleType=该刊全部是论著,可能不接收综述类等文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=ELIFE 在该细分领域可能是国际一流杂志,但是国内关注少,可能与很难投中有关吧,可以试试,但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=330712239'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=25, tagName=干细胞, createdHits=4), ImpactFactorTagDto(id=14566, tagName=分子, createdHits=4), ImpactFactorTagDto(id=2964, tagName=分子生物学, createdHits=4), ImpactFactorTagDto(id=4027, tagName=生物学, createdHits=3), ImpactFactorTagDto(id=11140, tagName=生命科学, createdHits=3), ImpactFactorTagDto(id=57838, tagName=生信, createdHits=2), ImpactFactorTagDto(id=198, tagName=口腔, createdHits=2), ImpactFactorTagDto(id=205, tagName=免疫, createdHits=2), ImpactFactorTagDto(id=43375, tagName=cell biology, createdHits=2), ImpactFactorTagDto(id=979, tagName=微生物, createdHits=2), ImpactFactorTagDto(id=6352, tagName=基础研究, createdHits=2), ImpactFactorTagDto(id=3349, tagName=细胞, createdHits=2), ImpactFactorTagDto(id=41434, tagName=cancer biology, createdHits=2), ImpactFactorTagDto(id=121, tagName=Immunology, createdHits=1), ImpactFactorTagDto(id=41285, tagName=医学综合, createdHits=1), ImpactFactorTagDto(id=20168, tagName=植物, createdHits=1), ImpactFactorTagDto(id=285, tagName=乳腺癌, createdHits=1), ImpactFactorTagDto(id=43716, tagName=植物抗逆, createdHits=1), ImpactFactorTagDto(id=15823, tagName=基因编辑, createdHits=1), ImpactFactorTagDto(id=43029, tagName=biomarker, createdHits=1), ImpactFactorTagDto(id=1474, tagName=微生物学, createdHits=1), ImpactFactorTagDto(id=716, tagName=代谢, createdHits=1), ImpactFactorTagDto(id=2005, tagName=细胞生物学, createdHits=1), ImpactFactorTagDto(id=229, tagName=细胞生物, createdHits=1), ImpactFactorTagDto(id=41557, tagName=植物逆境生理, createdHits=1), ImpactFactorTagDto(id=30333, tagName=综合, createdHits=1), ImpactFactorTagDto(id=41304, tagName=生物综合, createdHits=1), ImpactFactorTagDto(id=28730, tagName=生态学, createdHits=1), ImpactFactorTagDto(id=53412, tagName=基因蛋白, createdHits=1), ImpactFactorTagDto(id=23093, tagName=细胞疾病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.41), GetImpactFactorCiteScoreListResponse(year=2017, citescore=6.88), GetImpactFactorCiteScoreListResponse(year=2018, citescore=6.99), GetImpactFactorCiteScoreListResponse(year=2019, citescore=10.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=35.924), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=33.017), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=29.489), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=25.217), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=22.654)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - General Biochemistry, Genetics and Molecular Biology , rank=14/189), GetImpactFactorCiteScoreGradeResponse(smallClass=Neuroscience - General Neuroscience , rank=9/111), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - General Immunology and Microbiology , rank=7/41)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=BIOLOGY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2050-084X[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ELIFE[ta], article_number=1802, article_number_cn=129, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
ELIFE/eLife
ISSN
2050-084X
影响指数话题
预警等级
MedSci期刊指数
22.654 (MedSci实时期刊指数) | 33.9293 (5年期刊指数)
CiteScore值
10.6
h-index
139
h5-median
暂无数据
出版社/管理机构
杂志由 eLife Sciences Publications 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Irregular
出版年份
暂无数据
是否OA
被收录情况
Science Citation Index Expanded|BIOSIS Previews
JCR分区
BIOLOGY Q1
中科院分区
大类:生物 1区[Top]
小类:生物 2 区